George M Eid, MD

Dr. Synowiec is System Vice Chair for the Department of Neurology at Allegheny Health Network, and Associate Professor of Neurology at Drexel University. She primarily treats patients with central nervous system disorders, specializing in headache disorders and epilepsy. She has expertise in performing Botox injections, trigger point injections, occipital nerve blocks, and reading EEGs. Dr. Synowiec is board certified in Neurology by the American Board of Psychiatry and Neurology (ABPN). She is fellowship trained and ABPN subspecialty certified in Clinical Neurophysiology. She has additional subspecialty certification by the United Council for Neurologic Subspecialties in Headache Medicine, as well as a Certificate of Added Qualifications in Headache Medicine from the National Headache Foundation. She also serves on the medical advisory board of the Pennsylvania Department of Transportation. Dr. Synowiec is active in clinical practice, teaching, and researching disorders of the brain and nervous system.

Adam Dore, DO Adam Dore, DO, is the Division Chief of Rheumatology, specializing in diagnosing and treating a variety of rheumatic diseases. Dr. Dore provides expert care for patients with autoimmune and inflammatory conditions, utilizing advanced diagnostic and therapeutic approaches to manage complex rheumatologic disorders. Dr. Dore went to medical school at Philadelphia College of Osteopathic Medicine in Philadelphia, Pennsylvania. He completed his internship and residency in internal medicine at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania, and his fellowship in rheumatology at the University of North Carolina in Chapel Hill, North Carolina. Dr. Dore is board-certified in internal medicine and rheumatology. He welcomes patients ages 18 and older.

Susan Manzi, MD, MPH Dr. Manzi is currently Professor of Medicine and Chair of the Medicine Institute at Allegheny Health Network, Pittsburgh, PA. Dr. Manzi received her MD from the University of Pittsburgh School of Medicine. She completed her medical Internship and Residency at Duke University Medical Center, after which she completed her Fellowship in Rheumatology at UPMC, and received her Masters of Public Health (MPH) from the University of Pittsburgh Graduate School of Public Health. Dr. Manzi is recognized internationally as a pioneer in the investigation of premature cardiovascular disease in systemic lupus erythematosus and in the discovery of biomarkers for lupus diagnosis, monitoring and stratification. She has published over 250 scientific reports and book chapters and is inventor of the cell-bound complement activation products (CB- CAPs) technology platform for which she holds more than 20 patents. Her research program has received multi-million dollar support from many organizations including the NIH, the Department of Defense, the Lupus Foundation of America and the Arthritis Foundation. Dr. Manzi has served on Advisory Boards for the Food and Drug Administration and more than 20 pharmaceutical and biotech companies and has chaired or served on numerous NIH study sections and data safety monitoring boards. She has served Chair of the Board of Directors of the Lupus Foundation of America and currently serves as their Medical Director. Dr. Manzi has been recognized by the NIH for her outstanding mentorship of medical students, residents, graduate students and faculty.